Today: 9 June 2026
Sage Group share price in focus: AI partnership and buyback set up Jan 27 trading update
24 January 2026
2 mins read

Sage Group share price in focus: AI partnership and buyback set up Jan 27 trading update

London, Jan 24, 2026, 09:47 GMT — Market closed

  • Sage shares ended Friday at 1,029.1 pence, gaining 0.6%
  • Sage formed a global AI partnership with Augusta Labs to accelerate product launches
  • Over the last two sessions, the company continued its stock buyback under a programme set to run through March

Sage Group plc shares closed Friday 0.6% higher at 1,029.1 pence, following news of an AI partnership and ongoing share buybacks from the UK accounting and payroll software firm. During the session, the stock fluctuated between 1,013.5 and 1,034.0 pence, still hovering about 24% below its 52-week peak.

Timing is everything. Sage is pushing AI features aggressively right as investors shift focus from flashy demos to what actually drives revenue. In subscription models like Sage’s, that question comes up fast.

Sage is set to release its Q1 FY26 trading update on Tuesday, Jan. 27 at 08:30 a.m. GMT. Investors will be watching closely for steady subscription growth and any changes in pricing or demand, especially as smaller businesses reconsider their budgets.

On Thursday, Sage revealed a global deal with Lisbon-based Augusta Labs to embed applied AI engineering teams within its product organisation, aiming to expand its AI Centre of Excellence. “This partnership gives Sage the start-up speed we need,” said Manav Thiara, senior vice president at Sage. Augusta Labs co-founder Rodrigo Fernandes described AI as “entering its execution era.” The announcement highlighted projects across Sage Payroll, Sage Active, and Sage 300, including “agentic workflows” — AI tools designed to handle tasks end-to-end — plus faster data pipelines for real-time insights. sage.com

Sage revealed further buyback activity on Friday, acquiring 541,775 shares at a volume-weighted average price of 1,025.67 pence — a calculation that factors in trade size — with individual share prices ranging from 1,014.5 to 1,032.5 pence. These shares will be cancelled. The company confirmed the buyback programme is set to conclude by March 19 at the latest.

Just one day before, Sage revealed it snapped up 1,287,227 shares at a volume-weighted average price of 1,021.61 pence. In total, across two sessions, that’s around 1.83 million shares — equating to about £18.7 million at those average prices. It’s consistent activity, but nothing that shouts a major move.

The buyback traces back to November, when Sage unveiled a plan to repurchase up to 300 million pounds alongside full-year results revealing an increase in underlying operating profit. At the time, Chief Executive Steve Hare noted that customers using its AI-driven Copilot reported it was “saving them 10-12 hours a week” of administrative work. Reuters

Sage goes head-to-head with accounting software giants like Intuit and Xero, where adding automation to core workflows is the sector’s standard play. The key challenge for Sage now: can new partnerships and increased engineering muscle speed up product rollouts enough to win paying customers — all without sacrificing tight cost management?

But there’s a catch. Small and mid-sized firms often hit the brakes on upgrades when hiring stalls or budgets tighten, and investing in AI can push costs up before revenue catches up. If the Jan. 27 update signals softer demand or bigger spending, the buyback might not be enough to buoy sentiment.

Next week, investors will focus on subscription momentum, pricing trends, and any remarks on AI feature adoption. They’ll also track how aggressively Sage keeps returning cash via buybacks. The upcoming trigger: the Q1 FY26 trading update, set for Tuesday, Jan. 27.

Stock Market Today

  • Alibaba Stock Falls 18% Amid Heavy AI Investment
    June 9, 2026, 10:38 AM EDT. Alibaba shares have dropped 18% year-to-date, weighed down by the company's aggressive spending on artificial intelligence (AI) initiatives. This investment strategy has raised concerns among investors about its impact on short-term profitability. The stock's decline outpaces broader market trends and highlights the risks tech giants face when prioritizing long-term innovation over immediate earnings. Analysts note the move reflects Alibaba's commitment to staying competitive in the evolving technology landscape despite near-term challenges.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 24.01.2026

Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings
Next Story

Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings

Go toTop